Direkt zum Inhalt
Merck

HPLC Analysis of HSA and HSA Fusion Protein on Zenix®-C SEC-300

HPLC Analysis of HSA and HSA Fusion Protein on Zenix®-C SEC-300 application for HPLC

Materialien

Analytische Säule

Produkt-Nr.
Beschreibung
Preisangaben

Zenix®-C SEC-300 Gelfiltrations-Säule, 3 μm

L × I.D. 30 cm × 7.8 mm, 3 μm particle size, stainless steel

CONDITIONS

column

Zenix-C SEC-300, 30 cm x 7.8 mm I.D., 3 μm particles (Z777092)

mobile phase

(A) 150 mM sodium phosphate buffer, pH 7.0; (B) IPA; (95:5, v/v, A:B)

flow rate

1 mL/min

column temp.

25 °C

detector

UV, 280 nm

injection

10 μL

sample

HSA fusion peptide 5 mg/mL (MW 75 kD, pl 5.0, HSA conjugated peptide in diabetes treatment)

Beschreibung

Rechtliche Hinweise

Zenix is a registered trademark of Sepax Technologies